Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZETA vs MRNA✓SelectedUSD · MRNAZETA vs MRNA performance historyLatest closeAs of-8.41%11/20
Stock and ETF performance explorer

ZETA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+231.9%
MRNA return
-10.0%
Excess return
+241.9%
Maximum drawdown
-70.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.4%-2.2%-6.2%-8.2%
7D-19.5%-12.7%-6.8%-18.5%
30D-13.5%-20.7%+7.2%-11.9%
3M+6.0%+46.3%-40.3%+1.4%
6M+60.9%+305.2%-244.3%+24.1%
YTD+45.0%+561.2%-516.2%-0.3%
1Y+81.0%+772.1%-691.1%+17.0%
3Y+243.9%+147.0%+97.0%+160.0%
5Y+249.6%-26.1%+275.7%+211.3%
All+231.9%-10.0%+241.9%+227.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling